This distinction is especially important when someone lives with a person who is older, immunocompromised, or otherwise at elevated risk of severe illness. Even if the vaccinated person expects to experience only mild symptoms, they may still expose someone else to the virus.
What should you do if you have symptoms?
If you develop symptoms consistent with COVID-19, such as a sore throat, cough, fever, fatigue, or congestion, consider the possibility of a respiratory infection even if you are vaccinated.
A practical approach includes the following:
-
Stay away from others while you feel unwell. This reduces the chance of passing an infection to other people.
-
Consider testing. A suitable COVID-19 test may help clarify whether SARS-CoV-2 is the cause. Follow the test instructions and local guidance about repeat testing when an initial result is negative but symptoms continue.
-
Improve ventilation. Fresh air and better airflow can reduce the concentration of infectious respiratory particles indoors.
-
Wear a well-fitting mask when appropriate. A mask can help reduce the spread of respiratory particles, especially when contact with other people cannot be avoided.
-
Take extra care around high-risk individuals. Avoid close contact with people who may be more vulnerable to serious complications while you are potentially infectious.
-
Seek medical advice promptly if you are at higher risk. Some COVID-19 treatments must be started within a limited period after symptoms begin.
The CDC advises people at increased risk who develop symptoms of a respiratory virus to seek healthcare promptly because testing and treatment may be time-sensitive.
These precautions do not mean vaccination has failed. They recognize that preventing every infection is difficult and that reducing transmission requires several layers of protection.
Why mild symptoms still deserve attention
A vaccinated person may assume that a mild cough or sore throat is not worth taking seriously. In many cases, symptoms will indeed remain manageable. Nevertheless, mild illness can still be contagious, and symptoms alone cannot reliably identify which virus is responsible.
COVID-19, influenza, and other respiratory infections can produce overlapping symptoms. A person cannot determine with certainty whether they have COVID-19 simply by judging how they feel.
It is also possible for symptoms to change over time. Someone who initially feels only slightly unwell may later develop more significant symptoms. People at higher risk should be especially cautious about waiting until they feel seriously ill before seeking advice.
Vaccination is one layer of protection, not a substitute for responding sensibly when symptoms appear.
Why Protection Against Severe Disease Is So Important
The distinction between infection and severe disease is central to understanding the public-health value of COVID-19 vaccination.
An infection can have a wide range of outcomes. Some people never notice symptoms. Others experience several days of fever, fatigue, or respiratory discomfort. A smaller proportion develop serious complications that require medical attention, hospitalization, intensive care, or can result in death.
The risk of these outcomes is not distributed equally across the population. Age, underlying medical conditions, immune status, and other factors can influence the likelihood of becoming seriously ill.
For someone at high risk, preventing hospitalization may be a particularly important benefit even if the vaccine cannot eliminate the possibility of infection.
Imagine two hypothetical groups of people exposed to the same circulating virus. In both groups, some individuals become infected. If the vaccinated group experiences fewer hospitalizations and fewer critical cases, vaccination may still provide substantial protection even though infections have occurred in both groups.
This is why vaccine effectiveness cannot be evaluated simply by counting positive tests. Researchers also examine severe outcomes and compare them with the outcomes that would be expected in similar people without the same level of vaccine protection.
The CDC's summaries of vaccine effectiveness have documented reductions in hospitalization and critical illness following vaccination, while also noting that protection can decrease over time. A 2024–2025 vaccine study published in JAMA Network Open likewise estimated protection against hospitalization and more severe in-hospital outcomes during the study period. The precise estimates depend on the population, vaccine formulation, variant period, and outcome being measured.
These findings should not be interpreted as a promise that every vaccinated person will avoid severe illness. No preventive measure offers an absolute guarantee. Instead, they show why population-level risk reduction matters.
A person may experience an outcome that vaccination was intended to make less likely. That does not automatically invalidate the evidence that vaccination reduces risk across a population.
Relative risk and individual experience are not the same thing
Suppose a preventive measure reduces the probability of a particular outcome. Some people who use it will still experience that outcome because their risk was reduced rather than eliminated.
This is true of many medical interventions. A treatment may lower the chance of a complication without preventing every complication. A seat belt may reduce the risk of serious injury without making a vehicle collision harmless. A vaccine may reduce the risk of severe disease without guaranteeing that an infection cannot occur.
These comparisons are imperfect, but they illustrate a key principle: a measure can be effective even when it does not work in every individual case.
Individual experiences are important, especially when someone becomes seriously ill after vaccination. Such cases deserve appropriate medical care and, when indicated, reporting through relevant safety-monitoring systems. But determining the overall effect of a vaccine requires evidence from many people, not a single story.
This is why reliable medical guidance considers both individual circumstances and broader research findings.
Who Is More Likely to Become Seriously Ill?
Older adults and people with certain medical conditions may need additional attention to respiratory illness prevention and early treatment.
Although anyone can become infected with SARS-CoV-2, not everyone faces the same risk of severe disease.
Older adults
The risk of severe respiratory illness generally increases with age. Older adults may have immune systems that respond differently to infection and may be more likely to have other health conditions that complicate recovery.
For this reason, age is an important factor in discussions about vaccination and treatment. Older adults should follow the current recommendations that apply in their country and consult a healthcare professional if they are uncertain whether another dose is appropriate.
People with chronic health conditions
Certain medical conditions can increase the risk of serious COVID-19 complications. These may include cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, and other significant health problems.
Having a chronic condition does not mean that someone will necessarily develop severe COVID-19. The degree of risk varies with the condition, its severity, the person's age, and other aspects of their health.
A healthcare professional can help assess how these factors influence an individual's preventive needs.
People with weakened immune systems
Some people have reduced immune function because of a medical condition or treatment. In these circumstances, the immune response to vaccination may be weaker than expected, and the person may have a higher risk of serious infection.
People receiving immune-suppressing medication, undergoing certain cancer treatments, or living with particular immune disorders may need specific advice about vaccination timing and additional preventive measures.
The CDC publishes separate guidance for moderately and severely immunocompromised people because their vaccination needs may differ from those of the general population.
Pregnant people
Pregnancy can change how the body responds to respiratory infections. Certain physiological changes may increase the risk of severe illness, making prevention and timely medical advice important.
Pregnant people should discuss vaccination and treatment questions with a qualified healthcare professional who can consider their individual circumstances and current national recommendations.
People who have previously had COVID-19
Having had COVID-19 does not guarantee lifelong protection against reinfection. Immunity can change over time, and newer variants may differ from those encountered during a previous infection.